GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis
USA - NASDAQ:GEHC - US36266G1076 - Common Stock
71.4226 USD
+0.4 (+0.57%)
GEHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. GEHC has an excellent profitability rating, but there are concerns on its financial health. GEHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GEHC was profitable.
GEHC had a positive operating cash flow in the past year.
GEHC had positive earnings in each of the past 5 years.
GEHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.14%, GEHC belongs to the top of the industry, outperforming 83.51% of the companies in the same industry.
The Return On Equity of GEHC (22.19%) is better than 94.68% of its industry peers.
GEHC has a better Return On Invested Capital (7.77%) than 84.04% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROIC | 7.77% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
1.3 Margins
GEHC has a better Profit Margin (10.95%) than 84.04% of its industry peers.
In the last couple of years the Profit Margin of GEHC has grown nicely.
With an excellent Operating Margin value of 13.52%, GEHC belongs to the best of the industry, outperforming 81.38% of the companies in the same industry.
In the last couple of years the Operating Margin of GEHC has remained more or less at the same level.
GEHC has a worse Gross Margin (40.80%) than 65.96% of its industry peers.
In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% |
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
2. Health
2.1 Basic Checks
GEHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, GEHC has more shares outstanding
Compared to 1 year ago, GEHC has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.80, we must say that GEHC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.80, GEHC is in line with its industry, outperforming 59.57% of the companies in the same industry.
GEHC has a debt to FCF ratio of 7.38. This is a slightly negative value and a sign of low solvency as GEHC would need 7.38 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 7.38, GEHC is doing good in the industry, outperforming 74.47% of the companies in the same industry.
GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
GEHC's Debt to Equity ratio of 0.83 is on the low side compared to the rest of the industry. GEHC is outperformed by 73.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Altman-Z | 1.8 |
ROIC/WACC1
WACC7.8%
2.3 Liquidity
A Current Ratio of 1.18 indicates that GEHC should not have too much problems paying its short term obligations.
GEHC's Current ratio of 1.18 is on the low side compared to the rest of the industry. GEHC is outperformed by 82.98% of its industry peers.
A Quick Ratio of 0.95 indicates that GEHC may have some problems paying its short term obligations.
GEHC's Quick ratio of 0.95 is on the low side compared to the rest of the industry. GEHC is outperformed by 80.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.77% over the past year.
GEHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.32% yearly.
Looking at the last year, GEHC shows a small growth in Revenue. The Revenue has grown by 3.52% in the last year.
GEHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.41% yearly.
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
3.2 Future
GEHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.54% yearly.
GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y3.36%
EPS Next 2Y5.96%
EPS Next 3Y7.85%
EPS Next 5Y7.54%
Revenue Next Year4.23%
Revenue Next 2Y4.34%
Revenue Next 3Y4.39%
Revenue Next 5Y3.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.56, which indicates a correct valuation of GEHC.
Based on the Price/Earnings ratio, GEHC is valued cheaper than 85.11% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.46. GEHC is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 14.17, which indicates a correct valuation of GEHC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 86.70% of the companies listed in the same industry.
GEHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.56 | ||
| Fwd PE | 14.17 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaper than 86.17% of the companies in the same industry.
GEHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GEHC is cheaper than 83.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.29 | ||
| EV/EBITDA | 11.71 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)4.63
PEG (5Y)2.92
EPS Next 2Y5.96%
EPS Next 3Y7.85%
5. Dividend
5.1 Amount
With a yearly dividend of 0.19%, GEHC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.70, GEHC pays a better dividend. On top of this GEHC pays more dividend than 90.43% of the companies listed in the same industry.
With a Dividend Yield of 0.19, GEHC pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
2.80% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP2.8%
EPS Next 2Y5.96%
EPS Next 3Y7.85%
NASDAQ:GEHC (11/19/2025, 2:58:05 PM)
71.4226
+0.4 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.02%
Inst Owner Change0.77%
Ins Owners0.28%
Ins Owner Change-0.02%
Market Cap32.61B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Analysts79.29
Price Target88.76 (24.27%)
Short Float %2.47%
Short Ratio3.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.64%
PT rev (3m)0.01%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)1.3%
EPS NY rev (1m)0.68%
EPS NY rev (3m)11.68%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.56 | ||
| Fwd PE | 14.17 | ||
| P/S | 1.61 | ||
| P/FCF | 23.29 | ||
| P/OCF | 17.63 | ||
| P/B | 3.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.71 |
EPS(TTM)4.59
EY6.43%
EPS(NY)5.04
Fwd EY7.06%
FCF(TTM)3.07
FCFY4.29%
OCF(TTM)4.05
OCFY5.67%
SpS44.34
BVpS21.89
TBVpS-10.1
PEG (NY)4.63
PEG (5Y)2.92
Graham Number47.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROCE | 10.51% | ||
| ROIC | 7.77% | ||
| ROICexc | 9.18% | ||
| ROICexgc | 27.2% | ||
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% | ||
| FCFM | 6.91% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 78.67% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 5.09 | ||
| Cash Conversion | 55.91% | ||
| Profit Quality | 63.15% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.8 |
F-Score5
WACC7.8%
ROIC/WACC1
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
EPS Next Y3.36%
EPS Next 2Y5.96%
EPS Next 3Y7.85%
EPS Next 5Y7.54%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
Revenue Next Year4.23%
Revenue Next 2Y4.34%
Revenue Next 3Y4.39%
Revenue Next 5Y3.87%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.48%
EBIT Next 3Y10.61%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for GEHC stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 15.56 and the Price/Book (PB) ratio is 3.26.
Can you provide the financial health for GEHC stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.